FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

4074501000001101: Report only serious adverse reactions to the Committee on Safety of Medicines (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2004. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
10072401000001114 Report only serious adverse reactions to the Committee on Safety of Medicines en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
36829401000001111 Report only serious adverse reactions to the Committee on Safety of Medicines (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Report only serious adverse reactions to the Committee on Safety of Medicines Is a CSM warning status messages true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Somatropin(rbe) 36iu(12mg) inj cartridge(pdr for recon)+diluent - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rbe) 18iu(6mg) inj cartridge(pdr for recon)+diluent - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zomacton(rbe) 12iu(4mg) injection (pdr for recon)+diluent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Trilostane 60mg capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Trilostane 120mg capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Modrenal 120mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Modrenal 60mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Suprecur 5.5mg/5.5mL injection CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Synarel 200micrograms nasal spray CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nafarelin 200micrograms nasal spray - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Dimetriose 2.5mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Genotropin 16iu(5.3mg) injection cartridge CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Genotropin 36iu(12mg) injection cartridge CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Norditropin Penset 24iu(8mg) injection CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Norditropin Penset 12iu(4mg) injection CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin 36iu(12mg) injection - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Humatrope(rbe) 16iu(5.33mg) injection (pdr for recon)+diluent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Saizen(rmc) 10iu(3.33mg) injection (pdr for recon)+diluent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Genotropin KabiQuick(rbe) 4iu(1.3mg) prefilled syringe(pdr for recon)+diluent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Genotropin KabiQuick(rbe) 3iu(1mg) prefilled syringe(pdr for recon)+diluent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Genotropin KabiQuick(rbe) 2iu(0.7mg) prefilled syringe(pdr for recon)+diluent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Genotropin KabiVial(rbe) 16iu(5.3mg) injection (pdr for recon)+diluent+kit CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rbe) 4iu(1.33mg) injection (pdr for recon)+diluent - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rmc) 4iu(1.33mg) injection (pdr for recon)+diluent - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rmc) 10iu(3.33mg) injection (pdr for recon)+diluent - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(epr) 12iu(4mg) injection (pdr for recon)+diluent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rbe) 16iu(5.33mg) injection (pdr for recon)+diluent - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rbe) 16iu(5.33mg) injection cartridge - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(epr) 12iu(4mg) inj cartridge(pdr for recon)+diluent+kit CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(epr) 24iu(8mg) inj cartridge(pdr for recon)+diluent+kit CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rbe) 2iu(0.67mg) prefilled syringe(pdr for recon)+diluent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rbe) 3iu(1mg) prefilled syringe(pdr for recon)+diluent - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rbe) 2.4iu(0.8mg) prefilled syringe(pdr for recon)+diluent - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rbe) 4iu(1.33mg) prefilled syringe(pdr for recon)+diluent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rbe) 4iu(1.33mg) injection (pdr for recon)+diluent+kit CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rbe) 12iu(4mg) injection (pdr for recon)+diluent - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rbe) 16iu(5.33mg) injection (pdr for recon)+diluent+kit CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rmc) 24iu(8mg) injection (pdr for recon)+solvent - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rbe) 0.6iu(0.2mg) prefilled syringe(pdr for recon)+diluent - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rbe) 1.2iu(0.4mg) prefilled syringe(pdr for recon)+diluent - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Somatropin(rbe) 1.8iu(0.6mg) prefilled syringe(pdr for recon)+diluent - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Genotropin MiniQuick 3iu(1mg) prefilled syringe(pdr for recon)+diluent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Genotropin MiniQuick 1.2iu(0.4mg) prefilled syringe(pdr for recon)+diluent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Genotropin MiniQuick 2.4iu(0.8mg) prefilled syringe(pdr for recon)+diluent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Genotropin MiniQuick 1.8iu(0.6mg) prefilled syringe(pdr for recon)+diluent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Recombinant human follicle stimulating hormone beta 200iu/0.5mL injection - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Recombinant human follicle stimulating hormone beta 150iu/0.5mL injection - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Recombinant human follicle stimulating hormone beta 100iu/0.5mL injection - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Recombinant human follicle stimulating hormone beta 50iu/0.5mL injection - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Gestrinone 2.5mg capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Danazol 100mg capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Danazol 200mg capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Danol 100mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Danol 200mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Thyrogen 0.9mg powder for injection solution vial CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Bromocriptine 1mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Bromocriptine 10mg capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Parlodel 10mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Recombinant human follicle stimulating hormone alpha 37.5iu injection (pdr for recon)+diluent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Recombinant human follicle stimulating hormone beta 300iu/0.36mL cartridge - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Recombinant human follicle stimulating hormone beta 600iu/0.72mL cartridge - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Merional 150iu injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Merional 75iu injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Gonal-F 1200iu injection (pdr for recon)+diluent CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Recombinant human follicle stimulating hormone alpha 1200iu injection (pdr for recon)+diluent - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Puregon 600iu/0.72mL cartridge CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Puregon 300iu/0.36mL cartridge CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Crinone 4% vaginal gel CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Progesterone 8% vaginal gel - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Progesterone 4% vaginal gel - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Progesterone 100mg/2mL injection - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Gestone 100mg/2mL injection CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Gestone 50mg/1mL injection CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Gestone 25mg/1mL injection CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Medroxyprogesterone acetate 10mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Provera 2.5mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Medroxyprogesterone 2.5mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Climanor 5mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Romozin 400mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Romozin 300mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Romozin 200mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Troglitazone 400mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Troglitazone 300mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Troglitazone 200mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Glucobay 100mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Glucobay 50mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Acarbose 100mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Acarbose 50mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Adgyn Medro 5mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Provera 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Provera 5mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Potassium bicarbonate+citric acid 1.39g/1.14g soluble tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lubricating pessary CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
KY pessary CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Chlorhexidine gluconate 0.02% irrigation solution - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Chlorhexidine acetate 0.02% solution - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Solution R irrigation solution - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Solution G irrigation solution - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Mandelic acid 1% irrigation solution - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sodium hyaluronate 40mg/50mL bladder instillation - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Alprostadil 10micrograms injection cartridge continuation pack - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier

Start Previous Page 25 of 118 Next End

This concept is not in any reference sets

Back to Start